Locations:
SearchAdvertisement
Discussing research into improving CAR T-cell therapy efficacy
Making sense of the fast-moving treatment landscape
CAR T-cell therapy may offer reason for optimism that those with SLE can experience improvement in quality of life.
Explaining common misconceptions about chimeric antigen receptor therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Findings from large database important to inform clinical practice
Offers a new option for patients 60 and older with relapsed/refractory disease
What’s coming up at ASH and beyond
Higher type 2 immunity observed in persistent CAR T cells
CAR T-cell therapy, bispecifics and antibody drug conjugates have changed disease management
Advertisement
Advertisement